Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
September 6, 2018 - The FDA announced an update to the Warnings and Precautions section of dolutegravir-containing products drug labels regarding embryo-fetal toxicity.
Return to publications